CN Stock MarketDetailed Quotes

301207 Hualan Biological Vaccine Inc.

Watchlist
  • 16.60
  • +0.88+5.60%
Trading Aug 27 09:31 CST
9.98BMarket Cap12.40P/E (TTM)

Hualan Biological Vaccine Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
(FY)Dec 31, 2021
Assets
Current assets
Money funds
45.98%623.99M
6.82%640.98M
-58.40%375.78M
-27.94%734.26M
-77.04%427.45M
356.08%600.04M
45.01%903.26M
116.97%1.02B
--1.86B
-68.10%131.56M
Transactional financial assets
44.47%2.4B
12.63%1.6B
42.37%1.89B
-17.42%1.43B
61.29%1.66B
71.86%1.42B
65.82%1.33B
212.60%1.73B
--1.03B
82.36%825.82M
Notes receivable and accounts receivable
5.15%1.58B
10.80%1.99B
0.57%2.08B
-47.93%1B
24.30%1.5B
24.84%1.8B
30.04%2.07B
241.70%1.92B
--1.21B
-5.94%1.44B
-Accounts receivable
5.15%1.58B
10.80%1.99B
0.57%2.08B
-47.93%1B
24.30%1.5B
24.84%1.8B
30.04%2.07B
241.70%1.92B
--1.21B
-5.94%1.44B
Other receivables (including interest and dividends)
-31.78%2.56M
219.16%1.31M
332.65%3.65M
662.36%4M
459.72%3.75M
-79.97%411.02K
-57.82%843.87K
-86.17%524.82K
--670.77K
17.48%2.05M
-Other receivable
----
----
----
662.36%4M
----
-79.97%411.02K
----
-71.05%524.82K
----
17.48%2.05M
Advance payment
102.47%43.9M
39.37%28.18M
65.73%28.74M
-38.23%24.93M
-76.38%21.68M
-13.27%20.22M
-53.31%17.34M
-3.26%40.36M
--91.79M
1.98%23.31M
Inventories
0.05%321.52M
3.78%173.47M
1.70%291.55M
42.36%425.54M
-3.23%321.36M
55.63%167.16M
26.61%286.69M
23.34%298.91M
--332.1M
137.26%107.41M
Non-current assets due within one year
166.77%346.81M
187.28%373.46M
--371.3M
--369.14M
--130M
--130M
----
----
----
----
Other current assets
----
610.54%420.39M
----
--15.93M
-97.71%1.87K
59,524.87%59.17M
----
----
--81.74K
-76.98%99.23K
Total current assets
30.76%5.31B
24.66%5.23B
9.47%5.04B
-20.11%4.01B
-10.14%4.06B
65.77%4.19B
40.36%4.6B
167.43%5.01B
--4.52B
2.59%2.53B
Non Current assets
Fixed assets
----
----
----
-6.23%1.23B
----
-4.82%1.28B
----
123.46%1.31B
----
173.32%1.35B
Constru in process
----
----
----
578.94%3.3M
----
--3.26M
----
-99.89%485.75K
----
----
Productive biological assets
54.95%367.15K
49.03%965.1K
16.26%1.57M
-45.48%349K
-60.08%236.94K
-58.70%647.59K
-46.79%1.35M
0.79%640.15K
--593.62K
-30.04%1.57M
Intangible assets
-3.17%19.96M
-3.14%20.13M
-3.12%20.29M
-3.09%20.45M
-3.07%20.62M
-3.05%20.78M
-3.02%20.94M
-3.00%21.11M
--21.27M
-2.96%21.43M
Development expenditure
10.87%26.92M
8.71%26.27M
7.59%25.77M
7.70%25.02M
5.55%24.28M
7.27%24.16M
7.98%23.95M
6.01%23.23M
--23M
15.04%22.53M
Long deferred expense
-58.29%1.25M
-63.15%1.67M
----
-80.52%1.47M
-72.28%3M
-58.17%4.53M
-38.40%7.59M
--7.56M
--10.83M
--10.83M
Deferred tax assets
6.91%212.59M
4.51%217.97M
6.04%209.38M
1.25%200.28M
4.73%198.84M
14.03%208.56M
14.78%197.46M
4.17%197.8M
--189.86M
7.33%182.9M
Usufruct assets
----
----
----
----
----
----
-50.00%1.02M
-44.44%1.28M
--1.53M
-36.36%1.79M
Other non current assets
-28.94%1.09B
-0.83%1.33B
26.49%1.3B
88.13%1.31B
134.37%1.53B
230.14%1.34B
456.27%1.03B
307.39%694.71M
--652.14M
153.89%405.23M
Total non current assets
-17.87%2.5B
-3.96%2.77B
7.70%2.77B
23.46%2.79B
36.61%3.04B
44.56%2.88B
73.39%2.57B
57.28%2.26B
--2.22B
68.22%1.99B
Total assets
9.95%7.81B
13.00%8B
8.84%7.81B
-6.58%6.79B
5.28%7.1B
56.42%7.08B
50.63%7.17B
119.68%7.27B
78.97%6.75B
23.90%4.52B
Liabilities
Current liabilities
Short term loan
0.00%300M
0.00%300.18M
0.00%300M
-40.00%300M
-40.00%300M
-40.02%300.18M
-62.50%300M
66.67%500M
--500M
150.22%500.44M
Notes payable and accounts payable
-5.33%142.91M
-7.09%116.76M
-14.50%122.07M
-26.07%135.22M
-47.31%150.95M
-32.25%125.67M
2.58%142.77M
38.03%182.9M
--286.51M
75.90%185.5M
-Notes payable
97.21%19.86M
----
-84.49%3.13M
101.66%18.51M
-81.50%10.07M
-36.61%15.31M
-39.16%20.18M
-84.28%9.18M
--54.45M
-66.02%24.16M
-Accounts payable
-12.66%123.04M
5.80%116.76M
-2.97%118.94M
-32.82%116.7M
-39.29%140.88M
-31.60%110.36M
15.64%122.59M
134.36%173.72M
--232.06M
369.42%161.35M
Contract liabilities
103.91%6.87M
-0.41%2.67M
91.46%6.18M
32.31%4.6M
88.35%3.37M
74.10%2.68M
119.44%3.23M
82.88%3.48M
--1.79M
-18.42%1.54M
Salaries payable
--45.39K
----
----
--3.54K
----
----
----
----
----
-48.06%4.16M
Taxs payable
-72.26%2.29M
347.32%57.68M
102.92%84.2M
-97.16%2.47M
12.29%8.26M
-49.79%12.89M
-59.15%41.5M
9,015.25%87.22M
--7.35M
-84.06%25.68M
Other payable (including interest and dividends)
0.62%1B
10.30%1.21B
4.70%1.22B
-31.90%805.42M
16.84%998.58M
14.85%1.1B
22.04%1.17B
77.41%1.18B
--854.66M
-2.48%953.77M
-Other payable
----
----
----
-31.90%805.42M
----
14.85%1.1B
----
77.41%1.18B
----
-2.48%953.77M
Non current liabilities due within one year
----
----
----
----
----
----
4.75%1.07M
4.75%1.06M
--1.04M
4.75%1.03M
Other current liabilities
104.05%205.92K
0.14%80.09K
93.35%185.28K
36.86%137.84K
88.36%100.91K
75.01%79.97K
117.50%95.83K
82.61%100.72K
--53.57K
-8.48%45.7K
Total current liabilities
-0.29%1.46B
9.68%1.69B
4.76%1.73B
-36.25%1.25B
-11.51%1.46B
-8.09%1.54B
-17.38%1.65B
76.79%1.96B
--1.65B
14.88%1.67B
Current liabilities
Deferred tax liabilities
67.62%14.56M
137.44%15.22M
233.73%13.83M
176.34%10.39M
188.80%8.69M
156.71%6.41M
115.77%4.14M
133.62%3.76M
--3.01M
796.29%2.5M
Long term deferred income
-12.24%30.36M
-11.87%31.42M
-14.01%32.48M
-11.21%33.54M
-13.27%34.6M
-10.61%35.66M
-7.87%37.77M
-7.87%37.77M
--39.89M
564.84%39.89M
Lease liabilities
----
----
----
----
----
----
----
-79.53%271.83K
--540.52K
-56.15%806.11K
Total non current liabilities
3.79%44.92M
10.88%46.64M
10.48%46.31M
5.08%43.93M
-0.35%43.28M
-2.61%42.07M
-4.71%41.92M
-4.85%41.81M
--43.44M
432.15%43.19M
Total liabilities
-0.17%1.5B
9.71%1.73B
4.90%1.78B
-35.38%1.29B
-11.23%1.5B
-7.95%1.58B
-17.11%1.7B
73.67%2B
6.83%1.69B
17.19%1.72B
Shareholders equity
Paid-in capital
50.00%600.02M
50.00%600.02M
50.00%600.02M
50.00%600.02M
0.00%400.01M
11.11%400.01M
11.11%400.01M
11.11%400.01M
--400.01M
0.00%360M
Capital reserve funds
-5.66%2.92B
-5.62%2.92B
-5.63%2.91B
-5.87%2.9B
0.38%3.1B
251.06%3.09B
250.54%3.08B
250.54%3.08B
--3.08B
0.00%879.79M
Surplus reserve funds
43.07%286.16M
43.07%286.16M
27.44%200.01M
27.44%200.01M
27.44%200.01M
27.44%200.01M
65.71%156.94M
65.71%156.94M
--156.94M
65.71%156.94M
Retained profit
31.47%2.5B
36.16%2.46B
26.23%2.32B
10.22%1.8B
34.84%1.9B
28.10%1.81B
32.97%1.84B
97.85%1.63B
--1.41B
65.53%1.41B
Shareholders equity without minority interests
12.67%6.31B
13.95%6.26B
10.06%6.03B
4.34%5.5B
10.81%5.6B
95.74%5.5B
101.71%5.48B
144.21%5.27B
--5.05B
28.39%2.81B
Total shareholder equity
12.67%6.31B
13.95%6.26B
10.06%6.03B
4.34%5.5B
10.81%5.6B
95.74%5.5B
101.71%5.48B
144.21%5.27B
131.40%5.05B
28.39%2.81B
Total liabilityies and equity
9.95%7.81B
13.00%8B
8.84%7.81B
-6.58%6.79B
5.28%7.1B
56.42%7.08B
50.63%7.17B
119.68%7.27B
78.97%6.75B
23.90%4.52B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
Auditor
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
--
--
--
Dahua Certified Public Accountants (Special General Partnership)
(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022(FY)Dec 31, 2021
Assets
Current assets
Money funds 45.98%623.99M6.82%640.98M-58.40%375.78M-27.94%734.26M-77.04%427.45M356.08%600.04M45.01%903.26M116.97%1.02B--1.86B-68.10%131.56M
Transactional financial assets 44.47%2.4B12.63%1.6B42.37%1.89B-17.42%1.43B61.29%1.66B71.86%1.42B65.82%1.33B212.60%1.73B--1.03B82.36%825.82M
Notes receivable and accounts receivable 5.15%1.58B10.80%1.99B0.57%2.08B-47.93%1B24.30%1.5B24.84%1.8B30.04%2.07B241.70%1.92B--1.21B-5.94%1.44B
-Accounts receivable 5.15%1.58B10.80%1.99B0.57%2.08B-47.93%1B24.30%1.5B24.84%1.8B30.04%2.07B241.70%1.92B--1.21B-5.94%1.44B
Other receivables (including interest and dividends) -31.78%2.56M219.16%1.31M332.65%3.65M662.36%4M459.72%3.75M-79.97%411.02K-57.82%843.87K-86.17%524.82K--670.77K17.48%2.05M
-Other receivable ------------662.36%4M-----79.97%411.02K-----71.05%524.82K----17.48%2.05M
Advance payment 102.47%43.9M39.37%28.18M65.73%28.74M-38.23%24.93M-76.38%21.68M-13.27%20.22M-53.31%17.34M-3.26%40.36M--91.79M1.98%23.31M
Inventories 0.05%321.52M3.78%173.47M1.70%291.55M42.36%425.54M-3.23%321.36M55.63%167.16M26.61%286.69M23.34%298.91M--332.1M137.26%107.41M
Non-current assets due within one year 166.77%346.81M187.28%373.46M--371.3M--369.14M--130M--130M----------------
Other current assets ----610.54%420.39M------15.93M-97.71%1.87K59,524.87%59.17M----------81.74K-76.98%99.23K
Total current assets 30.76%5.31B24.66%5.23B9.47%5.04B-20.11%4.01B-10.14%4.06B65.77%4.19B40.36%4.6B167.43%5.01B--4.52B2.59%2.53B
Non Current assets
Fixed assets -------------6.23%1.23B-----4.82%1.28B----123.46%1.31B----173.32%1.35B
Constru in process ------------578.94%3.3M------3.26M-----99.89%485.75K--------
Productive biological assets 54.95%367.15K49.03%965.1K16.26%1.57M-45.48%349K-60.08%236.94K-58.70%647.59K-46.79%1.35M0.79%640.15K--593.62K-30.04%1.57M
Intangible assets -3.17%19.96M-3.14%20.13M-3.12%20.29M-3.09%20.45M-3.07%20.62M-3.05%20.78M-3.02%20.94M-3.00%21.11M--21.27M-2.96%21.43M
Development expenditure 10.87%26.92M8.71%26.27M7.59%25.77M7.70%25.02M5.55%24.28M7.27%24.16M7.98%23.95M6.01%23.23M--23M15.04%22.53M
Long deferred expense -58.29%1.25M-63.15%1.67M-----80.52%1.47M-72.28%3M-58.17%4.53M-38.40%7.59M--7.56M--10.83M--10.83M
Deferred tax assets 6.91%212.59M4.51%217.97M6.04%209.38M1.25%200.28M4.73%198.84M14.03%208.56M14.78%197.46M4.17%197.8M--189.86M7.33%182.9M
Usufruct assets -------------------------50.00%1.02M-44.44%1.28M--1.53M-36.36%1.79M
Other non current assets -28.94%1.09B-0.83%1.33B26.49%1.3B88.13%1.31B134.37%1.53B230.14%1.34B456.27%1.03B307.39%694.71M--652.14M153.89%405.23M
Total non current assets -17.87%2.5B-3.96%2.77B7.70%2.77B23.46%2.79B36.61%3.04B44.56%2.88B73.39%2.57B57.28%2.26B--2.22B68.22%1.99B
Total assets 9.95%7.81B13.00%8B8.84%7.81B-6.58%6.79B5.28%7.1B56.42%7.08B50.63%7.17B119.68%7.27B78.97%6.75B23.90%4.52B
Liabilities
Current liabilities
Short term loan 0.00%300M0.00%300.18M0.00%300M-40.00%300M-40.00%300M-40.02%300.18M-62.50%300M66.67%500M--500M150.22%500.44M
Notes payable and accounts payable -5.33%142.91M-7.09%116.76M-14.50%122.07M-26.07%135.22M-47.31%150.95M-32.25%125.67M2.58%142.77M38.03%182.9M--286.51M75.90%185.5M
-Notes payable 97.21%19.86M-----84.49%3.13M101.66%18.51M-81.50%10.07M-36.61%15.31M-39.16%20.18M-84.28%9.18M--54.45M-66.02%24.16M
-Accounts payable -12.66%123.04M5.80%116.76M-2.97%118.94M-32.82%116.7M-39.29%140.88M-31.60%110.36M15.64%122.59M134.36%173.72M--232.06M369.42%161.35M
Contract liabilities 103.91%6.87M-0.41%2.67M91.46%6.18M32.31%4.6M88.35%3.37M74.10%2.68M119.44%3.23M82.88%3.48M--1.79M-18.42%1.54M
Salaries payable --45.39K----------3.54K---------------------48.06%4.16M
Taxs payable -72.26%2.29M347.32%57.68M102.92%84.2M-97.16%2.47M12.29%8.26M-49.79%12.89M-59.15%41.5M9,015.25%87.22M--7.35M-84.06%25.68M
Other payable (including interest and dividends) 0.62%1B10.30%1.21B4.70%1.22B-31.90%805.42M16.84%998.58M14.85%1.1B22.04%1.17B77.41%1.18B--854.66M-2.48%953.77M
-Other payable -------------31.90%805.42M----14.85%1.1B----77.41%1.18B-----2.48%953.77M
Non current liabilities due within one year ------------------------4.75%1.07M4.75%1.06M--1.04M4.75%1.03M
Other current liabilities 104.05%205.92K0.14%80.09K93.35%185.28K36.86%137.84K88.36%100.91K75.01%79.97K117.50%95.83K82.61%100.72K--53.57K-8.48%45.7K
Total current liabilities -0.29%1.46B9.68%1.69B4.76%1.73B-36.25%1.25B-11.51%1.46B-8.09%1.54B-17.38%1.65B76.79%1.96B--1.65B14.88%1.67B
Current liabilities
Deferred tax liabilities 67.62%14.56M137.44%15.22M233.73%13.83M176.34%10.39M188.80%8.69M156.71%6.41M115.77%4.14M133.62%3.76M--3.01M796.29%2.5M
Long term deferred income -12.24%30.36M-11.87%31.42M-14.01%32.48M-11.21%33.54M-13.27%34.6M-10.61%35.66M-7.87%37.77M-7.87%37.77M--39.89M564.84%39.89M
Lease liabilities -----------------------------79.53%271.83K--540.52K-56.15%806.11K
Total non current liabilities 3.79%44.92M10.88%46.64M10.48%46.31M5.08%43.93M-0.35%43.28M-2.61%42.07M-4.71%41.92M-4.85%41.81M--43.44M432.15%43.19M
Total liabilities -0.17%1.5B9.71%1.73B4.90%1.78B-35.38%1.29B-11.23%1.5B-7.95%1.58B-17.11%1.7B73.67%2B6.83%1.69B17.19%1.72B
Shareholders equity
Paid-in capital 50.00%600.02M50.00%600.02M50.00%600.02M50.00%600.02M0.00%400.01M11.11%400.01M11.11%400.01M11.11%400.01M--400.01M0.00%360M
Capital reserve funds -5.66%2.92B-5.62%2.92B-5.63%2.91B-5.87%2.9B0.38%3.1B251.06%3.09B250.54%3.08B250.54%3.08B--3.08B0.00%879.79M
Surplus reserve funds 43.07%286.16M43.07%286.16M27.44%200.01M27.44%200.01M27.44%200.01M27.44%200.01M65.71%156.94M65.71%156.94M--156.94M65.71%156.94M
Retained profit 31.47%2.5B36.16%2.46B26.23%2.32B10.22%1.8B34.84%1.9B28.10%1.81B32.97%1.84B97.85%1.63B--1.41B65.53%1.41B
Shareholders equity without minority interests 12.67%6.31B13.95%6.26B10.06%6.03B4.34%5.5B10.81%5.6B95.74%5.5B101.71%5.48B144.21%5.27B--5.05B28.39%2.81B
Total shareholder equity 12.67%6.31B13.95%6.26B10.06%6.03B4.34%5.5B10.81%5.6B95.74%5.5B101.71%5.48B144.21%5.27B131.40%5.05B28.39%2.81B
Total liabilityies and equity 9.95%7.81B13.00%8B8.84%7.81B-6.58%6.79B5.28%7.1B56.42%7.08B50.63%7.17B119.68%7.27B78.97%6.75B23.90%4.52B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions --Unqualified opinion------Unqualified opinion------Unqualified opinion
Auditor --Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)------Dahua Certified Public Accountants (Special General Partnership)

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg